Atlas Trials

Adlai Nortye Biopharma Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Adlai Nortye Biopharma Co., Ltd.

RecordFirmDate
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression (NCT07686445)Adlai Nortye Biopharma Co., Ltd.2026-09-23
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations (NCT07252479)Adlai Nortye Biopharma Co., Ltd.2026-01-28
An Initial Evaluation of AN8025 in Solid Tumors (NCT07639047)Adlai Nortye Biopharma Co., Ltd.2025-11-01
AN0025 and Chemoradiotherapy Combination in Esophageal Cancer (NCT05191667)Adlai Nortye Biopharma Co., Ltd.2022-01-18
Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer (NCT05519059)Adlai Nortye Biopharma Co., Ltd.2021-10-11
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors (NCT04975958)Adlai Nortye Biopharma Co., Ltd.2021-09-07
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC (NCT04338399)Adlai Nortye Biopharma Co., Ltd.2020-12-12
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors (NCT04432857)Adlai Nortye Biopharma Co., Ltd.2020-08-20

Track Adlai Nortye Biopharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.